News

Given the established clinical overlap between PNH and aplastic anemia—2 hematopoietic stem cell disorders—this study provides important insight into response, safety, and survival in a high-risk ...
The OMNYPULSE pulsed field ablation (PFA) catheter had a 100% acute success rate, paired with a strong safety profile, in treating paroxysmal atrial fibrillation (AFib), according to the three-month ...
Clinical effectiveness of catheter ablation in atrial fibrillation (AF) is typically characterized by 12-month freedom from atrial tachyarrhythmia recurrence. However, freedom from AF burden may serve ...
Pulsed field ablation (PFA) is noninferior to cryoablation for the incidence of a first recurrence of atrial tachyarrhythmia in patients with paroxysmal atrial fibrillation (AFib), according to ...
On Feb. 23 the Vatican said Pope Francis' condition was still critical, however, he had had a “tranquil” night and that he “rested,” adding blood tests showed his anemia condition improved ...
Enrollment is under way to recruit patients for a phase 3 study designed to assess intravascular (IV) treatment with zaltenibart among individuals with paroxysmal nocturnal hemoglobinuria (PNH), ...
Chronic hemorrhoids, or piles, may cause iron deficiency anemia due to persistent blood loss. Symptoms may develop in severe cases of anemia. They can include tiredness, shortness of breath ...
Canadian Association of PNH Patients. "The availability of a new oral treatment option will provide meaningful benefits for Canadians who continue to struggle with anemia and dependence on blood ...
Canadian Association of PNH Patients. "The availability of a new oral treatment option will provide meaningful benefits for Canadians who continue to struggle with anemia and dependence on blood ...
MONTREAL, April 14, 2025 /CNW/ - Novartis Canada is pleased to announce that Fabhalta ® (iptacopan capsules) is now available across Canada for adult patients with paroxysmal nocturnal ...